Anita Langerød

Publications by Anita Langerød

32 publications found

Publications 2012

1. Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, Børresen-Dale AL, Levine AJ, Bargonetti J, Prives C (2012)
   Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
   Cell, 148 (1-2), 244-58
   PubMed 22265415

Publications 2011

1. Anaganti S, Fernández-Cuesta L, Langerød A, Hainaut P, Olivier M (2011)
   p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines
   Cancer Lett, 300 (2), 215-24
   PubMed 21071137
2. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, Wang Y, Kong B, Langerød A, Børresen-Dale AL, Kim SK, van de Vijver M, Sukumar S, Whitfield ML, Kellis M, Xiong Y, Wong DJ, Chang HY (2011)
   Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
   Nat Genet, 43 (7), 621-9
   PubMed 21642992
3. van den Broek AJ, Broeks A, Horlings HM, Canisius SV, Braaf LM, Langerød A, Van't Veer LJ, Schmidt MK (2011)
   Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
   Breast Cancer Res Treat, 130 (2), 599-608
   PubMed 21667122
4. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC (2011)
   Combining gene signatures improves prediction of breast cancer survival
   PLoS One, 6 (3), e17845
   PubMed 21423775

Publications 2010

1. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, Langerød A, Han W, Noh DY, Jeffrey SS, Huntsman DG, Børresen-Dale AL, Pollack JR (2010)
   Focal amplification and oncogene dependency of GAB2 in breast cancer
   Oncogene, 29 (5), 774-9
   PubMed 19881546
2. de Neergaard M, Kim J, Villadsen R, Fridriksdottir AJ, Rank F, Timmermans-Wielenga V, Langerød A, Børresen-Dale AL, Petersen OW, Rønnov-Jessen L (2010)
   Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment
   Am J Pathol, 176 (3), 1229-40
   PubMed 20133812
3. Holstege H, Horlings HM, Velds A, Langerød A, Børresen-Dale AL, van de Vijver MJ, Nederlof PM, Jonkers J (2010)
   BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
   BMC Cancer, 10, 654
   PubMed 21118481
4. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
   Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
   Sci Transl Med, 2 (38), 38ra47
   PubMed 20592421

Publications 2009

1. Olivier M, Petitjean A, Teague J, Forbes S, Dunnick JK, den Dunnen JT, Langerød A, Wilkinson JM, Vihinen M, Cotton RG, Hainaut P, IARC, EC FP6 (2009)
   Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration
   Hum Mutat, 30 (3), 275-82
   PubMed 19006239
2. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD, Jia M, Latimer C, Teague JW, Lau KW, Burton J, Quail MA, Swerdlow H, Churcher C, Natrajan R, Sieuwerts AM, Martens JW, Silver DP, Langerød A, Russnes HE et al. (2009)
   Complex landscapes of somatic rearrangement in human breast cancer genomes
   Nature, 462 (7276), 1005-10
   PubMed 20033038
3. Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A (2009)
   Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
   Mol Oncol, 3 (3), 214-9
   PubMed 19403344

Publications 2008

1. Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR (2008)
   CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer
   Mol Oncol, 2 (4), 327-39
   PubMed 19383354
2. Holm R, Kraus I, Skomedal H, Langerød A, Kristensen GB, Lyng H (2008)
   Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma
   Open Virol J, 2, 74-81
   PubMed 19440467
3. Pietersen AM, Horlings HM, Hauptmann M, Langerød A, Ajouaou A, Cornelissen-Steijger P, Wessels LF, Jonkers J, van de Vijver MJ, van Lohuizen M (2008)
   EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
   Breast Cancer Res, 10 (6), R109
   PubMed 19099573

Publications 2007

1. Chanock SJ, Burdett L, Yeager M, Llaca V, Langerød A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Børresen-Dale AL (2007)
   Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
   Breast Cancer Res, 9 (1), R5
   PubMed 17224074
2. Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S (2007)
   Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer
   Int J Cancer, 121 (11), 2532-8
   PubMed 17683073
3. Garcia-Closas M, Troester MA, Qi Y, Langerød A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS, Gram IT, Kristensen V, Børresen-Dale AL, Chanock S, Perou CM (2007)
   Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status
   Cancer Epidemiol Biomarkers Prev, 16 (11), 2269-75
   PubMed 18006915
4. Kapp AV, Jeffrey SS, Langerod A, Borresen-Dale AL, Han W, Noh DY, Bukholm IRK, Nicolau M, Brown PO, Tibshirani R (2007)
   Discovery and validation of breast cancer subtypes (vol 8, pg 101, 2007)
   BMC Genomics, 8, 101
5. Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS (2007)
   TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
   Breast Cancer Res, 9 (3), R30
   PubMed 17504517

Publications 2006

1. Baumbusch LO, Myhre S, Langerød A, Bergamaschi A, Geisler SB, Lønning PE, Deppert W, Dornreiter I, Børresen-Dale AL (2006)
   Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters
   Mol Cancer, 5, 47
   PubMed 17054774
2. Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R (2006)
   Discovery and validation of breast cancer subtypes
   BMC Genomics, 7, 231
   PubMed 16965636
3. Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børresen-Dale AL (2006)
   The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
   Clin Cancer Res, 12 (4), 1157-67
   PubMed 16489069

Publications 2005

1. Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
   Clin Cancer Res, 11 (2 Pt 2), 878s-83s
   PubMed 15701881

Publications 2004

1. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM (2004)
   Mutation of GATA3 in human breast tumors
   Oncogene, 23 (46), 7669-78
   PubMed 15361840
2. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS (2004)
   Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
   Mol Biol Cell, 15 (6), 2523-36
   PubMed 15034139

Publications 2003

1. Bukholm IR, Husdal A, Nesland JM, Langerød A, Bukholm G (2003)
   Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time
   Breast Cancer Res Treat, 80 (2), 199-206
   PubMed 12908823
2. Langerød A, Strømberg M, Chin K, Kristensen VN, Børresen-Dale AL (2003)
   BUB1 infrequently mutated in human breast carcinomas
   Hum Mutat, 22 (5), 420
   PubMed 14517964

Publications 2002

1. Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH (2002)
   High frequency of skewed X inactivation in young breast cancer patients
   J Med Genet, 39 (1), 30-3
   PubMed 11826021
2. Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL (2002)
   The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
   Cancer Epidemiol Biomarkers Prev, 11 (12), 1684-8
   PubMed 12496062

Publications 1999

1. Arver B, Claro A, Langerød A, Børresen-Dale AL, Lindblom A (1999)
   BRCA1 screening in patients with a family history of breast or ovarian cancer
   Genet Test, 3 (2), 223-6
   PubMed 10464672

Publications 1998

1. Helland A, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-Dale AL (1998)
   p53 polymorphism and risk of cervical cancer
   Nature, 396 (6711), 530-1; author reply 532
   PubMed 9859987